Join
Live feed
·
PRReleasevia Quantisnow
Tarsus Pharmaceuticals Inc. logo

Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease

ByQuantisnow·Wall Street's wire, on your screen.
TARS· Tarsus Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TARS (Tarsus Pharmaceuticals Inc.) and more on Quantisnow.